A Checkpoint in the Cell Cycle Progression as a Therapeutic Target to Inhibit HIV Replication
Author(s) -
Andrea Foli,
Maria Angela Maiocchi,
Julianna Lisziewicz,
Franco Lori
Publication year - 2007
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/521832
Subject(s) - cell cycle , cell cycle progression , biology , cell growth , viral replication , cell cycle checkpoint , cell , human immunodeficiency virus (hiv) , virology , s phase , cancer research , microbiology and biotechnology , immunology , virus , genetics , eukaryotic dna replication , proliferating cell nuclear antigen
Human immunodeficiency virus (HIV) expression is boosted after T lymphocyte stimulation. It is not known, however, in which phase(s) of the cell cycle HIV is maximally expressed. We demonstrate here that cell activation induces limited HIV expression and that progression to cell proliferation is required for optimal HIV replication. We also show that the G1/S cell cycle transition is a critical checkpoint in this process and that limiting progression at this step with antiproliferative drugs suppresses HIV replication. These results identify a specific phase of the cell cycle progression that is critical for HIV expression and suggest a new discrete target for anti-HIV treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom